December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
99 100 Next >
News headline image
Organogenesis Clears Major FDA Hurdle: Path to First Non-Surgical Biologic for Knee Osteoarthritis Widens
Via MarketMinute
Tickers ANIK ORGO PCRX SYK ZBH
Exposures Product Safety
News headline image
Ascendis Pharma Completes Strategic Trifecta with U.S. Launch of YUVIWEL and Seven-Year Orphan Exclusivity
Via MarketMinute
Topics Economy
Tickers ASND AZN BBIO BMRN
Exposures Interest Rates Product Safety
News headline image
Why Is Plus Therapeutics Stock Gaining Friday? ↗
Via Benzinga
Exposures Product Safety
News headline image
Why Is ImmunityBio Stock Rallying Thursday? ↗
Via Benzinga
Exposures Product Safety
News headline image
Amgen’s Subcutaneous TEPEZZA Data Sets New Gold Standard for Thyroid Eye Disease Treatment
Via MarketMinute
Tickers AMGN IMVT VRDN
Exposures Product Safety
News headline image
Kaplan Fox Reminds ImmunityBio, Inc. (NASDAQ: IBRX) Investors of a Securities Class Action Deadline on May 26, 2026
Via TheNewswire.com
Topics Lawsuit
Tickers IBRX
Exposures Financial Legal Product Safety
News headline image
Kaplan Fox Reminds ImmunityBio, Inc. (NASDAQ: IBRX) Investors of a Securities Class Action Deadline on May 26, 2026
Via NewMediaWire
Topics Lawsuit
Tickers IBRX
Exposures Financial Legal Product Safety
News headline image
The Radiopharmaceutical Renaissance: A Deep Dive into Telix Pharmaceuticals (TLX)
Via Finterra
Topics Economy Initial Public Offering
Tickers ASX:TLX ASX:XJO FIS JPM LLY NVS
Exposures Product Safety Securities Market Supply Chain
News headline image
The Science of Scale: An In-Depth Look at Regeneron Pharmaceuticals (REGN) in 2026
Via Finterra
Topics Earnings Economy Intellectual Property
Tickers ABBV AMGN LLY MRK REGN RHHBY
Exposures Financial Intellectual Property Interest Rates
News headline image
CORT SHAREHOLDER ACTION ALERT: Kaplan Fox Alerts Investors of a Class Action Lawsuit Against Corcept Therapeutics, Inc. (NASDAQ: CORT) and Lead Plaintiff Deadline on April 21, 2026
Via TheNewswire.com
Topics Lawsuit
Tickers CORT
Exposures Financial Legal Product Safety
News headline image
CORT SHAREHOLDER ACTION ALERT: Kaplan Fox Alerts Investors of a Class Action Lawsuit Against Corcept Therapeutics, Inc. (NASDAQ: CORT) and Lead Plaintiff Deadline on April 21, 2026
Via NewMediaWire
Topics Lawsuit
Tickers CORT
Exposures Financial Legal Product Safety
News headline image
Is This Dividend King With a 63-Year Dividend Streak A Buy Before April 14?
Via Barchart.com
Tickers JNJ
Exposures Product Safety
News headline image
Phio Pharmaceuticals Announces "Nobel Prize Winning Science Takes on Skin Cancer" in a Fireside Chat with Force Family Office on Wednesday, April 15, 2026
Via Newsfile
Tickers PHIO
Exposures Product Safety
News headline image
Q4 Earnings Highs And Lows: DexCom (NASDAQ:DXCM) Vs The Rest Of The Patient Monitoring Stocks
Via StockStory
Topics Artificial Intelligence
Tickers DXCM
Exposures Artificial Intelligence Product Safety
News headline image
DEADLINE ALERT: Kaplan Fox Alerts Investors to a Securities Class Action Against Corcept Therapeutics, Inc. (NASDAQ: CORT) - Deadline is April 21, 2026
Via TheNewswire.com
Topics Lawsuit
Tickers CORT
Exposures Financial Legal Product Safety
News headline image
DEADLINE ALERT: Kaplan Fox Alerts Investors to a Securities Class Action Against Corcept Therapeutics, Inc. (NASDAQ: CORT) - Deadline is April 21, 2026
Via NewMediaWire
Topics Lawsuit
Tickers CORT
Exposures Financial Legal Product Safety
News headline image
IMMUNITYBIO Deadline to Lead in Securities Class Action Lawsuit is May 26, 2026 - Contact Kaplan Fox
Via TheNewswire.com
Topics Lawsuit
Tickers IBRX
Exposures Financial Legal Product Safety
News headline image
IMMUNITYBIO Deadline to Lead in Securities Class Action Lawsuit is May 26, 2026 - Contact Kaplan Fox
Via NewMediaWire
Topics Lawsuit
Tickers IBRX
Exposures Financial Legal Product Safety
News headline image
Striking Beauties Boxing & Fitness Launches Women-Only Franchise
Via Press Release Distribution Service
Topics Product Recall
Exposures Legal Product Safety
News headline image
FDA Again Rejects Replimune Skin Cancer Therapy, Says Evidence Falls Short ↗
Via Benzinga
Exposures Product Safety
News headline image
Securities Class Action Deadline Against Corcept Therapeutics, Inc. (NASDAQ: CORT) - Contact Kaplan Fox Before April 21, 2026
Via NewMediaWire
Topics Lawsuit
Tickers CORT
Exposures Financial Legal Product Safety
News headline image
Securities Class Action Deadline Against Corcept Therapeutics, Inc. (NASDAQ: CORT) - Contact Kaplan Fox Before April 21, 2026
Via TheNewswire.com
Topics Lawsuit
Tickers CORT
Exposures Financial Legal Product Safety
News headline image
What's Going On With Replimune Stock Friday? ↗
Via Benzinga
Exposures Product Safety
News headline image
Deadline to Lead in Securities Fraud Lawsuit Against ImmunityBio, Inc. (NASDAQ: IBRX) is May 26, 2026 - Contact Kaplan Fox
Via NewMediaWire
Topics Fraud Lawsuit
Tickers IBRX
Exposures Financial Legal Product Safety
News headline image
Deadline to Lead in Securities Fraud Lawsuit Against ImmunityBio, Inc. (NASDAQ: IBRX) is May 26, 2026 - Contact Kaplan Fox
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers IBRX
Exposures Financial Legal Product Safety
News headline image
Telix Seeks Reset With FDA Filing While Sales Growth Holds Steady ↗
Via Benzinga
Exposures Product Safety
News headline image
What to Expect From Vertex Pharmaceuticals’ Q1 2026 Earnings Report
Via Barchart.com
Topics ETFs
Exposures Product Safety
News headline image
Federal Overreach or Financial Freedom? CFTC Sues States in Landmark Bid to Shield Prediction Markets from Gambling Labels
Via MarketMinute
Topics Derivatives Fraud Intellectual Property
Tickers CME DKNG FLUT HOOD IBKR
Exposures Derivatives Ethanol Financial
News headline image
Amgen Reclaims the Lead in Thyroid Eye Disease with Superior Subcutaneous TEPEZZA Data
Via MarketMinute
Topics Intellectual Property
Tickers AMGN ARM VRDN
Exposures Intellectual Property Product Safety
News headline image
FDA Flags Quality System Lapses At Medline Facility Over Device Risks ↗
Via Benzinga
Exposures Product Safety
< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.